Click here for Zoom Meeting ID: 977 0374 0749
Rich is the leader of Phillips Lytle’s Startups Practice Team and focuses his practice in corporate, finance and venture capital law, as well as complex mergers and acquisitions and commercial litigation. He provides corporate counsel to a broad spectrum of companies—from startup to Fortune 50—and has lectured extensively, particularly on the topics of corporate law, venture capital and entrepreneurship. Rich has served as a judge and mentor in numerous business plan events throughout New York State, including the New York Business Plan Competition (NYBPC) Venture B Plan and competitions sponsored by FuzeHub, Rensselaer Polytechnic Institute and Communitech. Rich is listed in The Best Lawyers in America© and was twice named the Best Lawyers® Corporate Law “Lawyer of the Year” in Albany. He received his J.D. from Albany Law School of Union University and his B.A. from the State University of New York at Albany. Click here to register.
Dr. Anderegg will discuss his team's work and how it resulted in new knowledge about the connection between tree physiology and risk of drought mortality in aspen forests and a new framework for mitigating climate change in forests and an unprecedented and comprehensive risk analysis, including from fire and insects, for Earth’s forests in the next century. Click here to register.
With the majority of biological studies conducted in academic settings but nearly all innovative new drug clinical trials sponsored by industry, improving translational research success rates for commercialization is critical to bringing new treatments to patients. Surveys of academic tech transfer offices and the biopharma industry executives working on such alliances cite as obstacles two highly controllable factors: disagreement about alliance performance metrics and misalignment of deal terms priorities. This panel will foster conversation about best practices for removing such obstacles to accelerate more promising ideas into clinical development for patients.
The panel will cover the following topics and take audience questions:
Advice for connecting with venture investors interested in start-ups based on academia-sourced IP.
In response to the absence of an established pipleline for diverse and inclusive hiring and to address staff retention challenges, we designed an Intern-to-Full Time Employee (FTE) pipeline as a sustainability tool for staffing and to ensure diverse hiring within our clinical research team. Our results suggest that partnering with underrepresented and underserved community groups can impact the dynamics of a growing team by increasing diversity, creating a culture of collaboration and mentorship and overall engagement in the work by interns and FTEs alike. Click here to register.